Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 98,094 | 73,665 | 56,315 | 25,285 | 159,519 |
| Depreciation Amortization | 60,050 | 44,843 | 29,829 | 14,371 | 58,999 |
| Income taxes - deferred | 28,660 | N/A | N/A | N/A | -17,872 |
| Accounts receivable | -6,367 | -9,599 | 4,192 | -8,075 | -21,671 |
| Other Working Capital | -65,971 | -23,242 | -35,239 | -16,714 | -14,547 |
| Other Operating Activity | 41,649 | 37,585 | 15,572 | 20,210 | 48,958 |
| Operating Cash Flow | $156,115 | $123,252 | $70,669 | $35,077 | $213,386 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,839 | 23,024 | 35,703 | 21,196 | 49,230 |
| PPE Investments | -34,882 | -26,610 | -21,262 | -10,697 | -41,041 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -129,000 |
| Purchase Sale Intangibles | -2,250 | -2,250 | -2,250 | N/A | N/A |
| Other Investing Activity | -6,611 | -6,177 | -4,585 | -18 | -4,119 |
| Investing Cash Flow | $-70,332 | $-9,763 | $9,856 | $10,481 | $-124,930 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,216 | 5,943 | 5,771 | 1,642 | 18,433 |
| Debt Repayment | -223 | -119 | -75 | -38 | -8,263 |
| Common Stock Issued | 2,855 | 873 | 494 | -4,685 | -4,849 |
| Common Stock Repurchased | -75,586 | -55,070 | -50,220 | -11,000 | -85,458 |
| Other Financing Activity | -687 | -679 | -675 | -422 | -816 |
| Financing Cash Flow | $-67,425 | $-49,052 | $-44,705 | $-14,503 | $-80,953 |
| Exchange Rate Effect | 210 | 219 | 260 | 118 | -190 |
| Beginning Cash Position | 151,844 | 151,844 | 151,844 | 151,844 | 144,531 |
| End Cash Position | 170,412 | 216,500 | 187,924 | 183,017 | 151,844 |
| Net Cash Flow | $18,568 | $64,656 | $36,080 | $31,173 | $7,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | 156,115 | 123,252 | 70,669 | 35,077 | 213,386 |
| Capital Expenditure | -34,882 | -26,610 | -21,262 | -10,697 | -41,041 |
| Free Cash Flow | 121,233 | 96,642 | 49,407 | 24,380 | 172,345 |